To lead a sustainable energy future, the European Commission and the European Investment Bank have announced an investment of €3.66 billion from the EU’s Modernisation Fund.
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
Here, Open Access Government discusses how the European Commission is supporting its Member States in creating a sustainable and resilient agricultural sector.
Jonathan Miles, Editor of Open Access Government, charts the importance of climate change adaptation, the impact of lockdown, transport and the environment in Europe, as highlighted by Eurocities.
Megan Warrender, Assistant Editor at Open Access Government, explores how Kadri Simson, European Commissioner for Energy is firmly set on achieving Europe’s ambitious targets for transforming the energy sector.
Executive Director at Bio-based Industries Joint Undertaking (BBI JU) Philippe Mengal discusses the new priorities and opportunities for bio-based industries in Europe, including new partnership, Circular Bio-based Europe Joint Undertaking (CBE JU).
Open Access Government explores the health priorities of Stella Kyriakides, Commissioner for Health and Food Safety, asking if lessons learned from the ongoing COVID-19 pandemic can help to improve European healthcare?.
Associate Professor Nikolaos P. Ventikos tells us about the MOSES research and innovation project, illustrating its contribution to sustainable European Short Sea Shipping (SSS) cargo transport.
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
Logan Finucan, Access Partnership, explains how the European Commission has launched the process towards the adoption of two adequacy decisions for personal dataflows to the UK.
Raimund Bleischwitz from University College London, Bartlett School of Environment, Energy and Resources (UCL BSEER), discusses systems thinking for net zero carbon and a circular economy.
The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".
President von der Leyen today (17 March) said that the Commission would limit vaccine deliveries to the UK if "the situation does not change" - suggesting that the drugmaker AstraZeneca is responsible for vaccination delays in the EU.
Tereza Borges, International Business Development at Lumenaza, speaks to Open Access Government about barriers to the full-scale adoption of renewables in this special energy focus.
From 2022, Horizon Europe funding applications by public bodies, research organisations and higher education institutions will only be considered if they have a gender equality plan.
Over the weekend, the Republic of Ireland suspended their use of AstraZeneca due to reports of blood clots in Norway - in response, the European Medicines Agency (EMA) says the AstraZeneca vaccine is still safe to use.
